12 Health Care Stocks Moving In Monday's Pre-Market Session
Portfolio Pulse from Benzinga Insights
In Monday's pre-market session, several health care stocks experienced significant price movements. Elevation Oncology, eFFECTOR Therapeutics, Shuttle Pharmaceuticals, PDS Biotechnology, Arcus Biosciences, and First Wave BioPharma were among the gainers, while Tilray Brands, Evoke Pharma, Theseus Pharmaceuticals, TScan Therapeutics, Freeline Therapeutics, and Minerva Surgical were among the losers.
May 29, 2023 | 1:06 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Evoke Pharma's shares declined by 16.58% to $1.56 during Monday's pre-market session, with a market cap of $5.2 million.
Evoke Pharma's 16.58% share price decline during the pre-market session suggests a negative short-term impact on the stock. The significant drop indicates weakening investor interest and demand for the stock.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
NEGATIVE IMPACT
Tilray Brands' shares decreased by 22.5% to $1.83 during Monday's pre-market session, with a market value of $1.1 billion.
Tilray Brands' 22.5% share price decrease during the pre-market session indicates a negative short-term impact on the stock. The significant drop suggests weakening investor interest and demand for the stock.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
eFFECTOR Therapeutics' stock rose 38.14% to $0.73 during Monday's pre-market session, with a market value of $30.9 million.
eFFECTOR Therapeutics' 38.14% stock price increase during the pre-market session suggests a positive short-term impact on the stock. The significant rise indicates strong investor interest and demand for the stock.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
Elevation Oncology's shares rose 89.4% to $5.7 during Monday's pre-market session, with a market cap of $138.7 million.
Elevation Oncology's significant share price increase during the pre-market session is likely to have a positive short-term impact on the stock. The 89.4% increase indicates strong investor interest and demand for the stock.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100